Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study

The association between oxaliplatin and 5-fluorouracil (5-FU) has been extensively reported to improve prognosis of gastric cancer patients. The present study is aimed at evaluating response rate and the toxicity profile of the association with oxaliplatin, 5-FU/lecovorin and epirubicin in gastric c...

Descripción completa

Detalles Bibliográficos
Autores principales: Neri, B, Pantaleo, P, Giommoni, E, Grifoni, R, Paoletti, C, Rotella, V, Pantalone, D, Taddei, A, Mercatelli, A, Tonelli, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360129/
https://www.ncbi.nlm.nih.gov/pubmed/17353926
http://dx.doi.org/10.1038/sj.bjc.6603644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360129/
https://www.ncbi.nlm.nih.gov/pubmed/17353926
http://dx.doi.org/10.1038/sj.bjc.6603644

Ejemplares similares